Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Invested Capital (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Invested Capital data on record, last reported at -$199.3 million in Q4 2025.

  • For Q4 2025, Invested Capital rose 81.54% year-over-year to -$199.3 million; the TTM value through Dec 2025 reached -$199.3 million, up 81.54%, while the annual FY2025 figure was -$199.3 million, 81.54% up from the prior year.
  • Invested Capital reached -$199.3 million in Q4 2025 per PTCT's latest filing, down from -$139.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $325.7 million in Q1 2021 and bottomed at -$1.1 billion in Q4 2024.
  • Average Invested Capital over 5 years is -$351.1 million, with a median of -$202.5 million recorded in 2022.
  • Peak YoY movement for Invested Capital: plummeted 552.73% in 2022, then surged 86.56% in 2025.
  • A 5-year view of Invested Capital shows it stood at $60.7 million in 2021, then tumbled by 552.73% to -$274.9 million in 2022, then plummeted by 190.38% to -$798.4 million in 2023, then tumbled by 35.21% to -$1.1 billion in 2024, then surged by 81.54% to -$199.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$199.3 million in Q4 2025, -$139.2 million in Q3 2025, and -$187.4 million in Q2 2025.